NASDAQ: VCYT

Veracyte is a cancer diagnostics company whose molecular tests read the biology of each patient’s tumor to help clinicians make clearer treatment decisions. It has tests for thyroid, prostate, breast, bladder and lung cancer, including the Afirma and Decipher tests, and they have helped guide care for more than 900,000 people.

Portfolio